AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
Type 2 diabetes, insulin resistance, and obesity are strongly associated and are a major health problem worldwide. Obesity largely results from a sustained imbalance between energy intake and expenditure. Therapeutic approaches targeting metabolic rate may counteract body weight gain and insulin res...
Main Authors: | Estefania Casana, Veronica Jimenez, Claudia Jambrina, Victor Sacristan, Sergio Muñoz, Jordi Rodo, Ignasi Grass, Miquel Garcia, Cristina Mallol, Xavier León, Alba Casellas, Víctor Sánchez, Sylvie Franckhauser, Tura Ferré, Sara Marcó, Fatima Bosch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050122000377 |
Similar Items
-
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice
by: Cristina Mallol, et al.
Published: (2017-07-01) -
FGF21 gene therapy as treatment for obesity and insulin resistance
by: Veronica Jimenez, et al.
Published: (2018-08-01) -
Integrated gene expression profiles reveal a transcriptomic network underlying the thermogenic response in adipose tissue
by: Jordi Rodó, et al.
Published: (2023-05-01) -
AAV genome modification for efficient AAV production
by: Walaa Asaad, et al.
Published: (2023-04-01) -
BMP7 functions predominantly as a heterodimer with BMP2 or BMP4 during mammalian embryogenesis
by: Hyung-Seok Kim, et al.
Published: (2019-09-01)